Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial

Treat-to-target (T2T) recommendations for gout

(2016) U Kiltz et al.   ANNALS OF THE RHEUMATIC DISEASES

2016 updated EULAR evidence-based recommendations for the management of gout

(2016) P Richette et al.   ANNALS OF THE RHEUMATIC DISEASES

Effects of Xanthine Oxidase Inhibitors on Cardiovascular Disease in Patients with Gout: A Cohort Study

(2015) Seoyoung C. Kim et al.   AMERICAN JOURNAL OF MEDICINE

An open-label, 6-month study of allopurinol safety in gout: The LASSO study

(2015) Michael A. Becker et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Uricosuric drugs

(2014) Mary H. Bach et al.   CURRENT OPINION IN RHEUMATOLOGY

Improving cardiovascular and renal outcomes in gout: what should we target?

(2014) Pascal Richette et al.   Nature Reviews Rheumatology

Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia

(2014) Roy Fleischmann et al.   RHEUMATOLOGY

Randomized Controlled Trial of Febuxostat Versus Allopurinol or Placebo in Individuals with Higher Urinary Uric Acid Excretion and Calcium Stones

(2013) D. S. Goldfarb et al.   Clinical Journal of the American Society of Nephrology

2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

(2012) Dinesh Khanna et al.   ARTHRITIS CARE & RESEARCH

Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment

(2011)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Pharmacokinetic and Pharmacodynamic Interaction Between Allopurinol and Probenecid in Patients with Gout

(2011) SOPHIE L. STOCKER et al.   JOURNAL OF RHEUMATOLOGY

Risk factors associated with renal lithiasis during uricosuric treatment of hyperuricemia in patients with Gout

(2010) Fernando Perez-Ruiz et al.   ARTHRITIS CARE & RESEARCH

Advances in gout: some answers, more questions

(2010) Jasvinder A Singh   ARTHRITIS RESEARCH & THERAPY

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

(2010) Michael A Becker et al.   ARTHRITIS RESEARCH & THERAPY

Clinical Efficacy and Safety of Successful Longterm Urate Lowering with Febuxostat or Allopurinol in Subjects with Gout

(2009) M. A. BECKER et al.   JOURNAL OF RHEUMATOLOGY

Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study

(2009) H. R. Schumacher et al.   RHEUMATOLOGY

Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A 28-week, phase III, randomized, double-blind, parallel-group trial

(2008) H. RALPH Schumacher et al.   ARTHRITIS AND RHEUMATISM

Treatment-failure gout: A moving target

(2008) N. Lawrence Edwards   ARTHRITIS AND RHEUMATISM